Joachim Kreuzburg - Sartorius Aktiengesellscha Chairman CEO

SRT3 Stock   215.60  0.40  0.19%   

Insider

Joachim Kreuzburg is Chairman CEO of Sartorius Aktiengesellschaft
Age 58
Phone49 551 308 0
Webhttps://www.sartorius.com

Sartorius Aktiengesellscha Management Efficiency

The company has return on total asset (ROA) of 0.1159 % which means that it generated a profit of $0.1159 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.417 %, meaning that it generated $0.417 on every $100 dollars invested by stockholders. Sartorius Aktiengesellscha's management efficiency ratios could be used to measure how well Sartorius Aktiengesellscha manages its routine affairs as well as how well it operates its assets and liabilities.
Sartorius Aktiengesellschaft has accumulated 1.87 B in total debt. Debt can assist Sartorius Aktiengesellscha until it has trouble settling it off, either with new capital or with free cash flow. So, Sartorius Aktiengesellscha's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sartorius Aktiengesellscha sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sartorius to invest in growth at high rates of return. When we think about Sartorius Aktiengesellscha's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Amy WakehamResmed Inc DRC
N/A
BE MBAResmed Inc DRC
50
Rene FaberSartorius Stedim Biotech
43
Jamie SamathIntuitive Surgical
52
John MackaySartorius Stedim Biotech
61
MD FACSIntuitive Surgical
66
Olivier GuitardSartorius Stedim Biotech
N/A
Vered KeisarResmed Inc DRC
N/A
Brett SandercockResmed Inc DRC
56
AM AMResMed Inc
80
Fredrik WidmanIntuitive Surgical
N/A
Gary LoebIntuitive Surgical
N/A
Heiko ImhlSartorius Stedim Biotech
N/A
Pascale BoisselSartorius Stedim Biotech
N/A
Amelie ButonSartorius Stedim Biotech
32
Julian NikolchevIntuitive Surgical
69
AM AMResmed Inc DRC
80
Robert DouglasResmed Inc DRC
63
Kaushik GhoshalResMed Inc
55
Constance BienfaitResmed Inc DRC
N/A
Marshall MohrIntuitive Surgical
67
Sartorius Aktiengesellschaft (SRT3) is traded on XETRA Stock Exchange in Germany and employs 15,942 people.

Management Performance

Sartorius Aktiengesellscha Leadership Team

Elected by the shareholders, the Sartorius Aktiengesellscha's board of directors comprises two types of representatives: Sartorius Aktiengesellscha inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sartorius. The board's role is to monitor Sartorius Aktiengesellscha's management team and ensure that shareholders' interests are well served. Sartorius Aktiengesellscha's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sartorius Aktiengesellscha's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rene Faber, Head Board
Petra Kirchhoff, Head Board
Rashid Maqbool, Head USA
Manfred Werner, Sr Auditing
Mei Wang, Head China
Patricia Spannagel, Head Goettingen
Joachim Kreuzburg, Chairman CEO
Rainer Lehmann, Member CFO
John Mackay, Head Board
Manohar Kuppusami, Head India

Sartorius Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sartorius Aktiengesellscha a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Sartorius Stock

Sartorius Aktiengesellscha financial ratios help investors to determine whether Sartorius Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Aktiengesellscha security.